Veracyte announces 10 Afirma thyroid test studies for ATA 2026 meeting

Bitget2026/11/02 14:03

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Veracyte announced 10 Afirma thyroid test abstracts for presentation at the American Thyroid Association meeting, Nov. 4-7, 2026, in Philadelphia.
The program includes two oral presentations and eight posters, with five studies conducted independently of the company.
Findings link gene expression to tumor invasion; other studies assess preoperative diagnosis, recurrence risk and potential treatment targets.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Veracyte Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611020900PRIMZONEFULLFEED9867862) on November 02, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Veracyte announces 10 Afirma thyroid test studies for ATA 2026 meeting

You may also like

Crypto prices